SCHEMBL8008181

SCHEMBL8008181

Cn1c(-c2ccccn2)nc(-c2ccc(C(C)(C)O)nc2)c1Sc1ccc(Cl)cn1

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
FAAH O00519 10/20 0.55
KCNH2 Q12809 3/20 0.51
PDE10A Q9Y233 1/20 0.37
SYK P43405 1/20 0.36
PTGS2 P35354 2/20 0.36
PTGS1 P23219 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.34
PRCP P42785 1/20 0.34
CNR1 P21554 1/20 0.33
ACHE P22303 1/20 0.33
PDE4A P27815 1/20 0.33
PDE4B Q07343 1/20 0.33
PDE4C Q08493 1/20 0.33
PDE4D Q08499 1/20 0.33
GRM5 P41594 1/20 0.33
SLC2A1 P11166 1/20 0.33
ALDH1A1 P00352 1/20 0.33
PKM P14618 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8011186 0.89 FAAH (0.47) FAAHKCNH2PDE10ASYKPTGS2
SCHEMBL1304088 0.89 FAAH (0.69) FAAHKCNH2PDE10ASYKPTGS2
SCHEMBL8003103 0.84 FAAH (0.52) FAAHKCNH2PDE10ASYKPTGS2
SCHEMBL8003046 0.84 FAAH (0.56) FAAHKCNH2PTGS2PTGS1L3MBTL1
SCHEMBL1304110 0.83 FAAH (0.55) FAAHKCNH2PTGS2PTGS1L3MBTL1
SCHEMBL1304003 0.83 FAAH (0.80) FAAHKCNH2PTGS2PTGS1L3MBTL1
SCHEMBL12106813 0.81 FAAH (0.54) FAAHKCNH2PTGS2PTGS1L3MBTL1
SCHEMBL1303664 0.81 FAAH (0.49) FAAHKCNH2CNR1ACHEPDE4A
SCHEMBL7993150 0.81 FAAH (0.54) FAAHKCNH2PDE10ASYKPTGS2
SCHEMBL1001460 0.81 FAAH (0.72) FAAHKCNH2SYKPTGS2PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8455528-B2 Imidazole derivatives useful as inhibitors of FAAH MERCK SHARP & DOHME CORP. (US) 2013-06-04 US disclosed
US-8455528-B2 Imidazole derivatives useful as inhibitors of FAAH MERCK SHARP & DOHME CORP. (US) 2013-06-04 US disclosed
US-20110269769-A1 IMIDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH MERCK SHARP & DOHME CORP. 2011-11-03 US disclosed
US-20110269769-A1 IMIDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH MERCK SHARP & DOHME CORP. 2011-11-03 US disclosed
WO-2009152025-A1 IMIDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH MERCK & CO., INC. (US) 2009-12-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110269769-A1 IMIDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH FAAH, FAAH2, HNMT FAAH 1/4885KCNH2 1076/4885PDE10A 1494/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.